Study of Diagnosis and Treatment for COVID-19 Based on “Fengwenjiashi” Theory/ 试从“风温夹湿”论治新型冠状病毒肺炎的理论探析

In December 2019, COVID-19 broke out in Wuhan, Hubei Province, China, and spread rapidly to various places China officially included the COVID-19 into the management of class B infectious diseases in accordance with Law on the Prevention and Control of Infectious Diseases Its rapid spread and severe outcomes resulted in a serious threat to people's lives and health After the epidemic disease broke out, Traditional Chinese medicine has played an important role due to its unique advantages In Traditional Chinese medicine, COVID-19 can be classified into “Yibing” It showed that the occurrence, development, transmission, and outcome of COVID-19 were similar to those of TCM “Fengwenjiashi” Patients with COVID-19 mainly experience the respiratory and digestive symptoms, and the lung and spleen are affected In this study, we tried to explore the syndrome differentiation and treatment for COVID-19 from “Fengwenjiashi” theory